Correlates of pre-hospital morphine use in ST-elevation myocardial infarction patients and its association with in-hospital outcomes and long-term mortality: The FAST-MI (French Registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction) programme

European Heart Journal

Volumn 37, Issue 13, 2016, Pages 1063-1071

  Puymirat, Etienne ^a,b,c   Lamhaut, Lionel ^b,c,d   Bonnet, Nicolas ^a,b,c   Aissaoui, Nadia ^b,e   Henry, Patrick ^f   Cayla, Guillaume ^g   Cattan, Simon ^h   Steg, Gabriel ^b,i,j   Mock, Laurent ^k   Ducrocq, Gregory ^b,i,j   Goldstein, Patrick ^l   Schiele, François ^m   Bonnefoy Cudraz, Eric ⁿ   Simon, Tabassome ^j,o,p   Danchin, Nicolas ^a,b,c  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

^e HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^f HÔPITAL LARIBOISIÈRE   (France)

^g DEPARTMENT OF NEUROLOGY   (France)

^h Department of Cardiology   (France)

ⁱ BICHAT HOSPITAL   (France)

^j INSERM   (France)

^k Clinique de Fontaine   (France)

^l LILLE UNIVERSITY HOSPITAL   (France)

^m UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁿ LOUIS PRADEL HOSPITAL   (France)

^o HÔPITAL SAINT ANTOINE   (France)

^p SORBONNE UNIVERSITÉ   (France)

more..

Author keywords

Acute myocardial infarction; Morphine; Opioids; ST elevation myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; AMINE; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; CYTOCHROME P450 2C19; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; METOCLOPRAMIDE; MORPHINE; MULTIDRUG RESISTANCE PROTEIN 1; NITRIC ACID DERIVATIVE; OPIATE; PRASUGREL; THIENOPYRIDINE DERIVATIVE; ABCB1 PROTEIN, HUMAN; MULTIDRUG RESISTANCE PROTEIN; NARCOTIC ANALGESIC AGENT;

ABSORPTION; ADULT; ANALGESIA; ARTICLE; BLEEDING; CEREBROVASCULAR ACCIDENT; DEATH; DRUG ABSORPTION; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPENSITY SCORE; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; SURVIVAL; THORAX PAIN; AGED; CLINICAL TRIAL; DRUG INTERACTION; EMERGENCY HEALTH SERVICE; EPIDEMIOLOGY; FRANCE; GENETICS; HOSPITALIZATION; MIDDLE AGED; NON-ST ELEVATED MYOCARDIAL INFARCTION; PAIN; PROCEDURES; RISK FACTOR; ST ELEVATION MYOCARDIAL INFARCTION; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME;

AGED; ANALGESICS, OPIOID; CYTOCHROME P-450 CYP2C19; DRUG INTERACTIONS; EMERGENCY MEDICAL SERVICES; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORPHINE; NON-ST ELEVATED MYOCARDIAL INFARCTION; P-GLYCOPROTEINS; PAIN; PLATELET AGGREGATION INHIBITORS; POLYMORPHISM, GENETIC; REGISTRIES; RISK FACTORS; ST ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

EID: 84965074871     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv567     Document Type: Article

References (20)

1. Anderson JL, Adams CD, Antman EM, Bridges CR, Califf RM, Casey DE Jr, Chavey WE II, Fesmire FM, Hochman JS, Levin TN, Lincoff AM, Peterson ED, Theroux P, Wenger NK, Wright RS, Jneid H, Ettinger SM, Ganiats TG, Philippides GJ, Jacobs AK, Halperin JL, Albert NM, Creager MA, DeMets D, Guyton RA, Kushner FG, Ohman EM, Stevenson W, Yancy CW. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013;61: e179-e347.
2. Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC), Steg PG, James SK, Atar D, Badano LP, Blömstrom-Lundqvist C, Borger MA, Di Mario C, Dickstein K, Ducrocq G, Fernandez-Aviles F, Gershlick AH, Giannuzzi P, Halvorsen S, Huber K, Juni P, Kastrati A, Knuuti J, Lenzen MJ, Mahaffey KW, Valgimigli M, van 't Hof A, Widimsky P, Zahger D. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012;33:2569-2619.
3. Hobl EL, Stimpfl T, Ebner J, Schoergenhofer C, Derhaschnig U, Sunder-Plassmann R, Jilma-Stohlawetz P, Mannhalter C, Posch M, Jilma B. Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial. J Am Coll Cardiol 2014;63:630-635.
4. Parodi G, Valenti R, Bellandi B, Migliorini A, Marcucci R, Comito V, Carrabba N, Santini A, Gensini GF, Abbate R, Antoniucci D. Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. J Am Coll Cardiol 2013; 61:1601-1606.
5. Montalescot G, van 't Hof AW, Lapostolle F, Silvain J, Lassen JF, Bolognese L, Cantor WJ, Cequier A, Chettibi M, Goodman SG, Hammett CJ, Huber K, Janzon M, Merkely B, Storey RF, Zeymer U, Stibbe O, Ecollan P, Heutz WM, Swahn E, Collet JP, Willems FF, Baradat C, Licour M, Tsatsaris A, Vicaut E, Hamm CW, ATLANTIC Investigators. Prehospital ticagrelor in ST-segment elevation myocardial infarction. N Engl J Med 2014;371:1016-1027.
6. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, Steg PG, Ferrières J, Danchin N, Becquemont L, French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) Investigators. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med 2009;360:363-375.
7. Mega JL, Close SL, Wiviott SD, Shen L, Walker JR, Simon T, Antman EM, Braunwald E, Sabatine MS. Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITONTIMI 38 trial: a pharmacogenetic analysis. Lancet 2010;376:1312-1319.
8. Hanssen M, Cottin Y, Khalife K, Hammer L, Goldstein P, Puymirat E, Mulak G, Drouet E, Pace B, Schultz E, Bataille V, Ferrières J, Simon T, Danchin N, FAST-MI 2010 Investigators. French Registry on Acute ST-elevation and non ST-elevation Myocardial Infarction 2010. FAST-MI 2010. Heart 2012;98:699-705.
9. Puymirat E, Teixeira N, Simon T, Steg PG, Schiele F, Lamblin N, Probst V, Juillière Y, Ferrières J, Danchin N, for the FAST-MI investigators. Patient education after acute myocardial infarction: cardiologists should adapt their message-French registry of acute ST-elevation or non-ST-elevation myocardial infarction 2010 registry. J Cardiovasc Med (Hagerstown) 2015;16:761-767.
10. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, SerruysPW, Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007;115:2344-2351.
11. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932-936.
12. Cambou J-P, Simon T, Mulak G, Bataille V, Danchin N. The French registry of Acute ST elevation or non-ST-elevation Myocardial Infarction (FAST-MI): study design and baseline characteristics. Arch Mal Coeur Vaiss 2007;100:524-534.
13. Danchin N, Puymirat E, Steg PG, Goldstein P, Schiele F, Belle L, Cottin Y, Fajadet J, Khalife K, Coste P, Ferrières J, Simon T, FAST-MI 2005 Investigators. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Circulation 2014;129:1629-1636.
14. deWaha S, Eitel I, Desch S, Fuernau G, Lurz P, Urban D, Schuler G, Thiele H. Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging. Clin Res Cardiol 2015;104:727-734.
15. Meine TJ, Roe MT, Chen AY, Patel MR, Washam JB, Ohman EM, Peacock WF, Pollack CV Jr, Gibler WB, Peterson ED, CRUSADE Investigators. Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. Am Heart J 2005;149: 1043-1049.
16. Nimmo WS, Heading RC, Wilson J, Tothill P, Prescott LF. Inhibition of gastric emptying and drug absorption by narcotic analgesics. Br J Clin Pharmacol 1975;2: 509-513.
17. McClennen W, Hornestam B, Jonsson UE, Held P. The plasma concentrations of isosorbide 5-mononitrate (5-ISMN) administered in an extended-release form to patients with acute myocardial infarction. Br J Clin Pharmacol 1995;39:704-708.
18. Parodi G, Bellandi B, Xanthopoulou I, Capranzano P, Capodanno D, Valenti R, Stavrou K, Migliorini A, Antoniucci D, Tamburino C, Alexopoulos D. Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Circ Cardiovasc Interv 2014;8.
19. Simon T, Steg PG, Gilard M, Blanchard D, Bonello L, Hanssen M, Lardoux H, Coste P, Lefèvre T, Drouet E, Mulak G, Bataille V, Ferrières J, Verstuyft C, Danchin N. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Circulation 2011; 123:474-482.
20. Lee G, Low RI, Amsterdam EA, DeMaria AN, HuberPW, Mason DT. Hemodynamic effects of morphine and nalbuphine in acute myocardial infarction. Clin Pharmacol Ther 1981;29:576-581.